O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

NCT00004892 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: O6-benzylguanine
DRUG: polifeprosan 20 with carmustine implant
PROCEDURE: conventional surgery

Sponsor

National Cancer Institute (NCI)